|Issuer:||SERA PROGNOSTICS, INC. (SERA)|
|Original Submission Date:|
C/O SERA PROGNOSTICS, INC.
2749 EAST PARLEYS WAY, SUITE 200 SALT LAKE CITY, UT 84109
|Title of Security||Transaction Date||2a. Deemed Execution Date||Transaction Code||Shares||Acquired or Disposed||Price per share||5. Amount of Securities Beneficially Owned Following Reported Transaction||6. Ownership Form Direct or Indirect||Nature of Indirect Ownership|
|Title of Derivative Security||Conversion or Exercise Price of Derivative Security||Transaction Date||Deemed Execution Date||Transaction Code||Number of Derivative Securities Acquired (A) or Disposed of (D)||Date Exercisable||Expiration Date||Title and Amount of Securities Underlying Derivative Security||Price of Derivative Security||Number of derivative Securities Beneficially Owned Following Reported Transaction(s)||Ownership Form: Direct (D) or Indirect (I)||Nature of Indirect Beneficial Ownership|
|STOCK OPTION (RIGHT TO BUY)||1.35||2022-06-03||deemed execution date||A||149,675 (a)||2032-06-03||class a common stock 149,675||$1.35||149,675||direct|
|f1||consists of stock options granted pursuant to sera prognostics, inc.'s non-employee director compensation policy and its 2021 equity incentive plan. these stock options vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the vesting commencement date, which is june 3, 2022.|